SCHEMBL1686804

SCHEMBL1686804

NCCOCC(O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20233902 0.95 USP2 (0.48)
Boric Acid SCHEMBL717513 0.93 USP2 (0.47)
SCHEMBL19549032 0.87 HTT (0.45)
SCHEMBL14762894 0.86 USP2 (0.59)
SCHEMBL2998408 0.86 USP2 (0.59)
SCHEMBL14762893 0.86 USP2 (0.59)
SCHEMBL1881943 0.84 USP2 (0.60)
SCHEMBL9784829 0.82 USP2 (0.66)
Monoethanolamine SCHEMBL1686811 0.82 USP2 (0.43)
SCHEMBL31526866 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065811-A1 Ethanolamine Glyceryl Ethers CLARIANT INTERNATIONAL LTD. (CH) 2011-03-17 US claimed
EP-1999103-B1 ETHANOLAMINE GLYCERYL ETHERS CLARIANT FINANCE BVI LTD (VG) 2009-07-29 EP claimed
JP-5170711-A None JP disclosed
US-12233132-B2 Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same SERINA THERAPEUTICS, INC. (US) 2025-02-25 US disclosed
CN-118178642-A Metal element lipid composition with atypical crystal structure, preparation method and application thereof 北京大学 2024-06-14 CN disclosed
US-20240108750-A1 POLYOXAZOLINE-LIPID CONJUGATES AND LIPID NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS INCLUDING SAME SERINA THERAPEUTICS, INC. (US) 2024-04-04 US disclosed
EP-4291242-A1 POLYOXAZOLINE-LIPID CONJUGATES AND LIPID NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS INCLUDING SAME Serina Therapeutics, Inc. (US) 2023-12-20 EP disclosed
CN-117098558-A Polyoxazoline-lipid conjugates, lipid nanoparticles comprising same, and pharmaceutical compositions 塞瑞纳治疗公司 2023-11-21 CN disclosed
CN-116019830-A Metal element lipid composition capable of activating IFN beta, preparation method and application thereof 北京大学 2023-04-28 CN disclosed
CN-115151641-A Human chromosome 9 open reading frame 72 (C9 ORF 72) iRNA agent compositions and methods of use thereof 阿尔尼拉姆医药品有限公司 2022-10-04 CN disclosed
US-20220249695-A1 POLYOXAZOLINE-LIPID CONJUGATES AND LIPID NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS INCLUDING SAME SERINA THERAPEUTICS, INC. (US) 2022-08-11 US disclosed
CN-100395296-C Aqueous ink capable of being erased by rubber and writing material using the same PILOT INK CO LTD (JP) 2008-06-18 CN disclosed
WO-2007107282-A1 ETHANOLAMINE GLYCERYL ETHERS CLARIANT FINANCE (BVI) LIMITED (VG) 2007-09-27 WO disclosed
WO-2007107282-A1 ETHANOLAMINE GLYCERYL ETHERS CLARIANT FINANCE (BVI) LIMITED (VG) 2007-09-27 WO disclosed
CN-1950474-A Adhesive for skin patch and preparation method thereof SHOWA DENKO KK (JP) 2007-04-18 CN disclosed
CN-1929996-A Thermally sensitive imageable element KODAK POLYCHROME GRAPHICS LLC (US) 2007-03-14 CN disclosed
CN-1379793-A Process for production of zwitterionic polyamines BASF AG (DE) 2002-11-13 CN disclosed
CN-1344168-A Ophthalmic composition ROHTO PHARMA (JP) 2002-04-10 CN disclosed
CN-1256294-A Aqueous ink capable of being erased by rubber and writing material using the same PILOT INK CO LTD (JP) 2000-06-14 CN disclosed
JP-H05170711-A DIHYDROXYETHER AMINE TOKUYAMA SODA CO LTD 1993-07-09 JP disclosed